Genovior Products - API
Product Description
GENOVIOR BIOTECH CORPORATION
-
Country/Region:Taiwan
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
Categories
Specifications
GENOVIOR BIOTECH CORPORATION
-
Country/Region:Taiwan
-
On CPHI since:2016
-
Certificates:1
-
Employees:100 - 249
Company types
Primary activities
More Products from GENOVIOR BIOTECH CORPORATION (7)
-
Product Semaglutide (GLP-1 Drug)
API < USD 500 per gram, COA available Finished product -
Product CDMO Services
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
... -
Product CDMO Services - API
small moleculepeptide
biologics -
Product CDMO Services - FDF drugs
VialsPrefilled Syringe
Injection Pen -
Product Genovior Products - FDF Drugs List 1
Azacitidine inj
Bortezomib inj
Docetaxel inj
Doxorubicin inj
Epirubicin inj
Fulvestrant inj
Gemcitabine inj
... -
Product Genovior Products - FDF Drugs List 2
Acyclovir inj
Colistin inj
Ganciclovir inj
Teicoplanin inj
Vancomycin inj
Levetiracetam inj
Valproate inj
... -
Product Products & Service
Products & Service
GENOVIOR BIOTECH CORPORATION resources (3)
-
Report Genovior company overview presentation
Company General Overview Introduction -
Brochure COMPANY PRESENTATION
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production
6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs
Generic/Peptide/Biosimilar projects available for out-licensing
Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
Biosimilar-Liraglutide, Ranibizumab, Denosumab
Others-Levetiracetam, Palonosetron, Valproate
